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1	  
Abstract 29	  
Manganese (Mn) is an essential trace element required for optimal functioning of cellular biochemical pathways in 30	  
the central nervous system. Elevated exposure to Mn through environmental and occupational exposure can cause 31	  
neurotoxic effects resulting inmanganism,a condition with clinical symptoms identical to idiopathic Parkinson’s 32	  
disease. Epigeneticsis now recognized as a biological mechanism involved in the etiology of various diseases. Here, 33	  
we investigated the role of DNA methylation alterations induced by chronic Mn (100µM) exposure in human 34	  
neuroblastoma (SH-SY5Y) cells in relevance to Parkinson’s disease. A combined analysis of DNA methylation and 35	  
gene expression data for Parkinson’s disease associated genes was carried out. Whole genome bisulfite conversion 36	  
and sequencing (WGBS) indicates epigenetic perturbation of key genes involved in biological processes associated 37	  
with neuronal cell health.  Integration of DNA methylation data with gene expression reveals 38	  
epigeneticalterationstoPINK1, PARK2and TH, genes that play critical roles in the onset of Parkinsonism. The present 39	  
study suggests that Mn-induced alteration of DNA methylation of PINK1-PARK2 may influence mitochondrial 40	  
function and promote Parkinsonism.Our findings provide a basis to further explore and validate the epigenetic basis 41	  
of Mn induced neurotoxicity. 42	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APC  - Adenomatous polyposis coli 45	  
ATP2B2 - ATPase Plasma Membrane Ca2+ Transporting 2 46	  
CXXC1  - DNA-Binding Protein With PHD Finger And CXXC Domain 47	  
DLK1  - Delta-Like 1 Homolog (Drosophila 48	  
DRD2  - Dopamine receptor D2 49	  
GBE1  - 1,4-alpha-glucan-branching enzyme 50	  
Mn  - Manganese 51	  
NRXN3  - Neurexin 3 52	  
NSF  - N-Ethylmaleimide Sensitive Factor 53	  
PAN2  - Poly(A) Specific Ribonuclease Subunit 54	  
PARK2  - Parkin RBR E3 Ubiquitin Protein Ligase 55	  
PINK1  - PTEN-induced putative kinase 1  56	  
PPI  - Protein Protein Interaction 57	  
SLC25A4 - Solute Carrier Family 25 Member 4 58	  
SNCA  - Synuclein Alpha 59	  
STUB1  - STIP1 Homology And U-Box Containing Protein 1 60	  
TH  - Tyrosine Hydroxylase   61	  
VDAC  - Voltage-dependent anion-selective channel protein 1 62	  
WGBS  - Whole genome bisulfite conversion and sequencing 63	  
YWHAZ - Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta 64	  
2	  
 65	  
1. Introduction 66	  
Manganese (Mn) is naturally present in the environment and is a vital trace element required for proper functioning 67	  
of cellular biochemical pathways. Although Mnis essential for human physiology, elevated exposure can elicit 68	  
neurotoxic effects on the developingcentral nervous system (CNS)  (Erikson et al. 2007; Tamm et al. 2008).  Miners 69	  
and workers of ferroalloy, smelting and metallurgy industries are occupational populations exposed to manganese 70	  
(Finkelstein MM 2007; Lucas et al. 2015). Manganese containing pesticide formulations such asmaneb and paraquat 71	  
are used in agriculture to treat various plant pathologies (Roede et al. 2011). Methylcyclopentadienyl manganese 72	  
tricarbonyl (MMT) used as an petrol anti-knock additive also releases Mn as a combustion product in the atmosphere 73	  
(Crump 2000). Recently high exposure to Mn has been reported to occur with use of psychoactive stimulantsin 74	  
recreational drugs(de Bie et al. 2007).The concentration of Mn in drinking water also was found to exceed the WHO 75	  
regulatory standard (400µg/L) (WHO 2006).  Significant levels of Mnhave been detected in children hair samples 76	  
and breast milk inpopulations residing in the vicinity of industrial steel plant (Sharma R. 2005). Therefore, the main 77	  
paths of environmental exposure toMnin the general population occursthrough intake of contaminated drinking water, 78	  
dietary foods and inhalation of ambient air with elevated level of manganese (Roede et al.2011; ATSDR 2012). 79	  
High occupational and environmental exposure to Mn has been reported to cause manganism,a condition with 80	  
neurological symptoms similar to those of idiopathic Parkinson’s disease (Settivari et al. 2013). Clinically, the 81	  
symptom includes tremors, bradykinesia, rigidity,postural instability and facial muscle spasms. The low chronic level 82	  
of exposure to Mn for prolonged period have been found to be associated with elevated risk of developing 83	  
Parkinson’s disease (Gorell et al. 2004). 84	  
Parkinson’s disease is characterized by the progressive loss of dopaminergic neurons in substantianigra pars 85	  
compacta (SNpc) with subsequent depletion of dopamine, impairing the execution of coordinated movements 86	  
(Anumantha et al. 2012). Recent evidence suggest thatMn deposition occurs in substantianigra region and hence may 87	  
be postulated to be associated with the etiology of Parkinson’s disease (Park et al. 2007).  88	  
Epigenetics entails the study of heritable changes in gene expression that occur independent of modifications to 89	  
nucleotide sequences (Schnekenburger M 2007). Control of gene expression is essential for normal physiological 90	  
functioning of cell and the epigenetic machinery has an important role in regulating these processes. Epigenetic 91	  
regulation includes of DNA methylation, histone modifications and miRNA expression. The involvement of 92	  
epigenetic deregulation in the cause of various neurodegenerative disorders such as Parkinson’s, Huntington 93	  
Alzheimer and other mood disorders has been suggested (Migliore L 2009). Environmental toxicants that induce 94	  
epigenetic alterations have been implicated in the susceptibility and progression of environmentally mediated chronic 95	  
diseases (Baccarelli and V. Bollati 2009; Anumantha et al. 2012).  96	  
The generation of oxidative stress through mitochondrial accumulation of Mn and subsequent mitochondrial 97	  
respiratory dysfunction is thought to be primarily responsible for neurotoxic effects of manganese (McCubrey JA and 98	  
Lahair MM 2006).  For example, Mn has been reported to cause apoptotic cell death via oxidative stress in the human 99	  
neuroblastoma SH-SY5Y cell line(Stephenson et al. 2013). Exposure to heavy metals such as As, Pb, Cd and Ni 100	  
3	  
generates reactive oxygen species that may alter the level of DNA methylation in rat and other animal 101	  
models(Martinez R 2011). 102	  
DNA methylation alterations occur primarily at CpG sites through addition of a methyl group to the 5' position of 103	  
cytosines. Around 70% of the CpGs sites are constitutively methylated in human genome, while unmethylatedCpGs 104	  
are generally located in CpG islands associated with promoter regions of genes (Martin C 2007). Methylation 105	  
modifications at CpG sites can induce conformational changes to chromatin and thereby modulate accessibility of 106	  
gene promoter regions to the transcription machinery (Orphanides G 2002).  107	  
Human population is inevitably exposed to manganese in the environmental and occupational settings. It is evident 108	  
from the epidemiological studies and available literature that populations exposed to low chronic levels of Mn have a 109	  
propensity to develop idiopathic Parkinson’s disease (Kim et al. 2002). However, the hypothesis involving the 110	  
potential role of epigenetic mechanisms in manganese induced neurotoxicity has not been explored (Tarale et al. 111	  
2016). 112	  
In the present study we investigated the impact of chronic Mn exposure on whole genome DNA methylation levels 113	  
and profiling of differentially methylated genes. We used the dopaminergic human neuroblastoma (SH-SY5Y) cell 114	  
line as a model to explore the role of DNA methylation alterations induced by Mn and its possible association 115	  
withParkinson’s disease. In support of our DNA methylation data, we also correlated differentially methylated 116	  
regions with expression levels ofParkinson’s disease associated genes. The results of the present investigation provide 117	  
insight how epigenetic mechanisms may promote manganese-induced idiopathic Parkinson’s disease.    118	  
 119	  
2. Material and Methods 120	  
2.1 Cell line  121	  
 Human neuroblastoma (SH-SY5Y) cell line was procured from National Center for Cell Science (NCCS), 122	  
Pune, India. Cells were grown in Ham’s F-12 medium supplemented with 10% fetal bovine serum, 100 U/mL 123	  
penicillin, 50 µg/mL streptomycin, and 25 µg/mL Fungizone. Cells were maintained at 37∘C in a humidified 124	  
atmosphere with 5% CO2. 125	  
2.2 Chronic Mn2+ exposure 126	  
 SH-SY5Y cells were seeded in 25mm2 flask (5 x105 cells/ml) and grown up to 70% confluence level. After 127	  
achieving the 70% confluence level, cells were exposed to 100 µM of Mn2+ in the form of MnCl2 (Sigma Aldrich, 128	  
USA). The dose of Mn2+for exposure in this study was selected based on the published research articles and 129	  
preliminary studies (Bornhorst et al. 2013; Stephenson et al. 2013). Chronic exposure of Mn2+was given for the 130	  
period 30 days, three controls and three exposed flask were maintained during the period of exposure. Medium was 131	  
subsequently changed at every third day and after each passage throughout the exposure period. Cells were treated 132	  
with Mn2+after each passage as the cells get adhere to the flask.  133	  
2.3 Whole-genome (DNA) methylation sequencing and data processing  134	  
4	  
 At the end of exposure period, cells were harvested for the whole genome DNA methylation sequencing 135	  
and analysis as follows. 136	  
2.3.1 Isolation of genomic DNA 137	  
SH-SY5Y cells were harvested and suspended in lysis buffer (500µl of TNE buffer, 25 µl of 20% sodium 138	  
dodecyl sulfate (SDS), 7.5 µl of proteinase K (20mg/ml)). Samples were then incubated at 37°C for 3 hrs. After 3 h 139	  
incubation, 250µl of phenol: chloroform: isoamyl alcohol (25:24:1) was added to cell lysate and mixed well, further 140	  
samples were kept for 30 min at room temperature. Later samples were centrifuged at 14000g for 15 min. After 141	  
centrifugation aqueous layer was collected to new eppendorf tubes and DNA was precipitated with 90% ethanol and 142	  
25µl of 0.3 M sodium acetate. Samples were centrifuged at 14000g for 10 min to pellet out the precipitated DNA. 143	  
Precipitated DNA was washed with 70% ethanol and again re-centrifuged. Finally DNA was air dried and re-144	  
suspended in DNase free water. Quantification of genomic DNA was carried out using 145	  
ND8000Nanodropspectrophotometer. 146	  
2.3.2 Bisulfite conversion 147	  
 EZ DNA Methylation GoldTM Kit (Zymo Research) was used for the bisulfite conversion of 20µl 148	  
(200ng/µl) of genomic DNA. 20µl of each DNA sample was mixed with 130µl of CT conversion reagent and 149	  
programmed at thermal cycler as; 98º C for 10 min, 64º C for 2.5 hrs, 4º C for 20 hrs. After the incubation, 600µl M 150	  
binding buffer was added to tubes and transferred to Zymo spin IC column. Columns were centrifuged at 10000g for 151	  
30 sec. Following centrifugation, columns were washed with M wash buffer. Later 200µl of M desulphonation 152	  
buffer was added to columns and incubated at room temperature for 20 min followed by centrifugation at max 153	  
speed. Columns were then washed with M buffer and bisulfite converted genomic DNA was eluted with M elution 154	  
buffer. 155	  
2.3.3 Whole genome bisulfite sequencing 156	  
Whole genome bilsulfite sequencing was carried out using EpiGnomeTM Methyl-Seq Kit on IlluminaHiseq 157	  
2500.  100ng of bisulfite converted genomic DNA samples were mixed with 2µl DNA primer and incubated for 5 158	  
min at 90º C. After the incubation, 4µl of EpiGnome DNA synthesis premix, 0.5µl of 100mM DTT and 0.5µl of 159	  
EpiGnome polymerase was added to samples was and programmed on thermal cycler (25ºC for 5 min, 42ºC for 30 160	  
min, 37ºC for 2 min). Later 1.0µl of exonuclease was added to each samples and reaction was programmed on 161	  
thermal cycler (37ºC for 10 min, 95ºC for 3 min, 25ºC for 2min). At the end of programme, 8µl of Terminal Tagging 162	  
master mix (7.5µl of EpiGnomeTM Terminal Tagging premix and 0.5µl DNA polymerase) was added to each sample 163	  
tubes and programmed on thermal cycler (25ºC for 30 min, 95ºC for 3 min and hold at 4ºC). Prior proceeding DNA 164	  
library preparation, DNA was purified using AMPure XP system to yield di-tagged DNA. EpiGnome Index PCR 165	  
Primer kit was used to generate whole genome bisulfite library. To 22.5µl of di-tagged DNA, 24µl of Failsafe PCR 166	  
premix E, 1.0µl of EpiGnome forward primer, 1.0µl of EpiGnome reverse primer and 0.5µl of Failsafe PCR 167	  
Enzyme was added and programmed on thermal cycler for 10 cycles as 95ºC for 30 seconds, 55ºC for 3 min, 68ºC 168	  
5	  
and final extension at 68ºC for 7 mins. Whole genome bisulfite library was then purified by using AMPure XP 169	  
system.Totalyield of WGB library was quantified using Qubitfluorometer and size distribution of WGB library was 170	  
analyzed using2100 bioanalyzer (Agilent). Whole genome bisulfite sequencing (Paired End) of bisulfite library was 171	  
carried out on IlluminaHiseq 2500 using Illumina SBS and Cluster kit. 172	  
2.3.4 Bismark alignment 173	  
Whole genome bisulfite sequencing (WGBS) was carried out to generate the DNA methylation map of SH-SY5Y 174	  
cell line chronically exposed to Mn (100µM). Two biological replicates, each of control and exposed SH-SY5Y cell 175	  
line were sequenced. Bismark alignment in control and exposed samples mapped an average of 62% of reads the 176	  
genome. The 90% of the sequenced data passed Q30 phred quality score. According to Bismark alignment mapping 177	  
efficiency within a range of 60-68% was considered as the best alignment percentage for reads of>80 base pairs of 178	  
length. The whole genome bisulfite sequencing (WGBS) data was submitted to National center for Biotechnology 179	  
Information (NCBI) Sequence Read Archive (SRA) repository and can be accessed (SRP075314; SRP075316; 180	  
SRP075243; SRP075313). The publically submitted whole genome DNA methylation data may be further explored 181	  
using other bioinformatics tools to obtain additional information in relevant to manganese neurotoxicity 182	  
 183	  
2.3.5 Methylation analysis and identification of differentially methylated genes  184	  
 The base calling pipeline (HiSeq Control Software 2.2.38) was used for demultiplexing prior to the 185	  
generation of fast-q-sequence files, i.e by separating the libraries according to their indexes. Passed filter (PF) is a 186	  
cluster that fulfills the default Illumina quality criteria; % of bases (PF) with a quality score greater or equal to 30 187	  
was used as a cutoff to remove sequences produced from clusters with low signal to noise ratio (e.g. overlapping 188	  
DNA clusters). A 6-8 bp pair DNA sequence tag found in adaptor sequence to uniquely identify each library; used at 189	  
demultiplexing step. This filtered reads are aligned to the Human Genome reference (hg19/GRCH37 Assembly). 190	  
Bismark tool (Version – V 0.10.1) was used for the alignment of bisulfite converted genome sequences. Each 191	  
cytosine (C) present in raw reads was extracted from alignment output file (SAM file) using Bismark. The position 192	  
of every cytosine (C), depending on cytosine (C) context (CpG, CHC and CHH) methylated cytosine (C) was 193	  
labeled as “+” (forward read) while unmethylated cytosine (C) labeled as “-” (reversed read). Every methylated 194	  
cytosine (C) was annotated against human reference genome using Varimat tool. aEach cytosine (C) was tracked to 195	  
its original location in the genome based on its chromosome position to identify differentially methylated regions. 196	  
Methylation difference between control and Mn2+ exposed cells was calculated by using DMAP (Differential 197	  
Methylation Analysis Package for RRBS and WGBS data). We screened for differentially methylated genes 198	  
between Control and Mn-treated samples having methylation difference above 0.1 (hyper orhypomethylation). The 199	  
Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 (https://david.ncifcrf.gov/) 200	  
was used for functional annotation clustering of differentially methylated genes.  201	  
2.4 Gene expression profiling for Parkinson’s disease associated genes 202	  
6	  
 SH-SY5Y cells were harvested at the end of exposure period for the isolation of total RNA. Trizol reagent 203	  
(Invitrogen) was used for the isolation of total RNA. Quantification of total RNA was carried out using NanoDrop 204	  
8000 spectrophotometer. 2000ng of RNA was converted to cDNA using the RT2 first strand kit (Qiagen, Germany) 205	  
as per the manufacturer instructions. The Human Parkinson's Disease RT² Profiler PCR Array (Qiagen, Germany) 206	  
profiles the expression of 84 key genes directly or potentially involved in Parkinson's disease . Each RT² Profiler 207	  
PCR array contains 12 controls that were used for the normalization of RT-PCR results. Applied Biosystems7300 208	  
real time PCR was used for the relative quantification and RT-PCR was performed as per the manufacturer protocol. 209	  
ΔΔCt method of relative quantification was used for the calculation of fold change and interpretation of control 210	  
wells. 211	  
3. Results 212	  
3.1 Methylation profiling  213	  
 We scanned the genome of Mn-treated and untreated SH-SY5Y cells for cytosine methylation by mapping 214	  
methylated and unmethylated cytosines to a virtual, bisulfite converted human genome. Chronic exposure to 215	  
manganese resulted in overall slight increase in the percentage of methylation density at CpG sites from 70.4%to 216	  
73.6%(Figure 1A and B). Methylation of cytosines has also been detected at non-CpG sites in neuronal DNA (Ryan 217	  
Lister, Eran A. Mukamel, Joseph R. Nery, Mark Urich et al. 2013). We therefore, examined our WGBS data setsfor 218	  
the presence ofmethylation events at CHG and CHH sites(H = A/C/T). In context of non-CpG sites anincrease in 219	  
methylation levels was detectedat CHG sites,from 3.4% to 19.7%(Figure 1C). Similarly,at CHH sites, methylation 220	  
was markedly elevated, from 3.7%to 25.4%(Figure 1D).  221	  
The expression of genes is influenced by cytosine modifications. To map transcriptional start sites (TSS) and to 222	  
identify genes associated with TSS regionson their original locations in chromosomes, we used VariMAT to 223	  
annotate the observed cytosine methylation events. This gives the list of differentially methylated genes that are 224	  
linked with altered state of CpG methylation. 225	  
3.2 Differentially methylated gene analysis 226	  
 We examined if a genome-wide trend for methylation of TSS could be detected. Methylation densities of 227	  
CpG sites within 5 kilobase (kb) regions upstream and downstream of TSS were determined with 200 base pair (bp) 228	  
genomic bins using our WGBS data. This analysis suggested a subtle trend towards methylated TSS and increased 229	  
levels of cytosine modification downstream, in the gene bodies of the Mn exposed samples (Supplementary figure 230	  
2).The WGBS data were further analyzed for identification of genomic sequences associated with a distinct CpG 231	  
methylation status. Chromosome wise analysis identified 24868 differentially methylated genes. Genes from this list 232	  
were further shortlisted based on the p_value (<0.05) to obtain a list of around 10213 differentially methylated genes 233	  
at statistically significant level (Supplementary file 1). The list of genes was again screened, based on <0.1% 234	  
methylation difference/change, yielding 6846 differentially methylated regions of genes. The heat map showing the 235	  
differential methylation status for genes with >0.1methylation difference is given in supplementary figure S1.The 236	  
7	  
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 was used for functional annotation 237	  
clustering of differentially methylated genes. The hypermethylated and hypomethylated genes were separately 238	  
analyzed using theDAVID database for functional annotation and clustering. DAVID based analysis shows that the 239	  
hypermethylated genes are involved in metal ion binding (25%), cytoskeleton (16%), chromatin modification (12%), 240	  
regulation of transcription (7%), apoptosis and iron binding (13%) (Figure 2A). The hypomethylated genes are 241	  
involved in regulation of signal transduction (38%), transcription (15%), neuron differentiation and development 242	  
(5%), synaptic transmission and MAPK signaling pathways (9%) (Figure 2B).The important hypermethylated genes 243	  
regulating the synaptic transmission are PINK1, PARK2, SMAD7, VGF, DBH, GDNF, TH, GRIK3, and NGF.  The 244	  
genes responsible for regulating the apoptosis such as MGMT, CASP3, CARD14, MAPK8, MAP3K7, NGFR, 245	  
YWHAZ were also found to be hypermethylated. The several inflammatory genes, including HRH1, IGF2, ITGB6, 246	  
MAP2K3, YWHAZ, LYN and MASP1were found to be hypomethylated. In summary, DAVID analysis reveals that 247	  
manganese exposure alters the DNA methylation status of genes involved in the important biological pathways. The 248	  
perturbation in the regulation of biological pathways via methylation alteration of associated genes may be 249	  
responsible for the neurotoxic mechanism of manganese. 250	  
  251	  
3.3 Correlation of differentially methylated genes with knowngenes inParkinson ’s diseaseRT² Profiler 252	  
array   253	  
The DNA methylation profiling approach identifies genes potentially involved in pathways related to Parkinson’s 254	  
disease. In order to correlate and validate the differentially methylated genes with their relative level of gene 255	  
expression, we used the Human Parkinson's Disease RT² Profiler PCR Array (Qiagen, Germany). From a total of 84 256	  
genes screened with this PCR array, we found that34 genes had significantly diminished expression levels (p<0.05) 257	  
in the Mn treated SH-SY5Y cells. To assess if this set of down-regulated genes is enriched for certain functional 258	  
pathways or networks, the DAVID database was used for annotation and clustering based on the gene ontology. The 259	  
identified 34 genes were found to be involved in three biological pathways, including neuronal development and 260	  
differentiation (17 genes), dopamine metabolic process (8 genes), and ubiquitin mediated proteolysis (5 genes) 261	  
(Figure 3).Important genes associated with these pathways are ATP2B2, DRD2, NRXN3, SLC25A4, SNCA, TH, 262	  
VDAC, PARK2, PINK1, NSF, PAN2, STUB1. These three pathways are known to play a role in the pathology of 263	  
Parkinson’s disease. The same pathways that we identified to be deregulated using the RT² expression profiler were 264	  
also flaggedby a DAVID analysis of our list of differentially methylated genes.The differentially methylated genes 265	  
identified in the WGBS screen were compared to the list of 34 genes identified in the RT2 PCR expression profiler 266	  
array for human Parkinson’s disease and additionally with genes that have been reported in the literature to be 267	  
associated with Parkinson’s disease. This type of comparison could indicate a probable connection between 268	  
manganese induced DNA methylation alteration and changes in expression of Parkinson’s disease associated genes. 269	  
Based on this analysis we identified 119differentially methylated genes from our WGBS data set,which is shown in 270	  
a heat map(Figure 4). 271	  
8	  
Correlation of DNA methylation and gene expression in the present study identifies 10 genes in relevance to 272	  
Parkinson’s disease (APC, ATP2B2, CXXC1, DLK1, GBE1, NSF, PARK2, PINK1, TH, and YWHAZ) (Figure 5). 273	  
Among these 10 genes; TH, PARK2 and PINK1 are particularly recognized as important players in the etiology of 274	  
Parkinson’s disease as they have a significant role in the proteosomal degradation, protein kinase activity and 275	  
dopamine biosynthesis (Satake et al. 2009)Table 1 gives the list of 10 genes with their status in DNA methylation 276	  
profile and RT2 PCR gene expression analysis. The methylation alteration of these critical genes shows the probable 277	  
association between manganese exposure and Parkinson’s disease at an epigenetic level. The STRING database 278	  
(Search Tool for the Retrieval of Interacting Genes/Proteins) is mainly devoted to documenting known and predicted 279	  
functional protein-protein interactions. Our STRING analysis reveals a significant biological association between 280	  
the genes as group with PPI (p-value<0.0002) (Figure 6). The major biological process (GO) altered in connection 281	  
to Parkinson’s disease has been highlighted in the figure 6.  282	  
 283	  
4. Discussion 284	  
Epigenetics has gained recognition as a biological mechanism that is associated with the manifestation of 285	  
various human diseases. The interaction between gene and environment is thought to be, in part at least, mediated 286	  
via epigenetic mechanisms.  Epigenetic changes have already been implicated in certain cases of Parkinson’s disease 287	  
(Moyano et al. 2011). There is growing evidence suggesting a link between manganese exposure and Parkinson’s 288	  
disease (Racette et al. 2012). However there are limited studies that aimed to determine the connection between 289	  
manganese exposure with deregulation in epigenetic mechanisms leading toParkinson’s disease (Nannan et al. 290	  
2016). 291	  
The human neuroblastoma cell line (SH-SY5Y) has been used as ex vivo cell model to investigate the neurotoxic 292	  
mechanism of manganese (Li et al. 2010). In the present study we chronically exposeda neuroblastoma cell line to 293	  
Mn2+ (100µM) for a period of 30 days, followed by WGBS and gene expression analysis for Parkinson’s disease 294	  
associated genes. Hypermethylation of CpG sites within gene promoter regions generally correlates with repression 295	  
of gene expression(Nan et al., 1998). In contrast, non-CpG cytosine modificationshavebeen detected in active 296	  
genomic regions in human and mouse brain (Lister et al. 2013; Guo et al. 2014). In the present study we observed an 297	  
increase of non-CpG methylation, particularly at CHH sites (figure 1C and 1D). The methyl CpG binding protein 2 298	  
(MECP2) plays an essential role in normal neuronal development (Chahrour et al. 2009) and appears to 299	  
modulatetranscription by interaction with both methylated CpG sites and methylated mCAsites (Matthew et al. 300	  
2013). The overall methylation increase at both CpG and non-CpG sites observed in the present study may be 301	  
associated with analtereddistribution of MECP2. 302	  
The WGBS data was further analyzed to identify specific genes with altered methylation. The list of significantly 303	  
hypermethylated and hypomethylated genes was submitted to Database for Annotation, Visualization and Integrated 304	  
Discovery (DAVID) for functional annotation and clustering (Dennis et al. 2003). DAVID analysis indicates the 305	  
involvement of these differentially methylated genes in multiple important biological pathways such as regulation of 306	  
9	  
neuronal differentiation and development, synaptic transmission, signal transduction, inflammation and programmed 307	  
cell death. Exposure to manganese has been reported to alter the DNA methyaltion status of various CpG loci during 308	  
the neurodevelopmental process (Maccani et al. 2015 ).  The hypomethylation of inflammatory nitric oxide synthase 309	  
gene (iNOS) was reported responsible for elevated signs of Parkinsonism among the Mn miners (Susan et al. 2014). 310	  
DAVID based functional classification of genes in the present work also identifies the hypomethylation of 311	  
inflammatory genes. 312	  
It is important to recognize there may not be a direct correlation between the DNA methylation status and 313	  
expression profile of genes (Jones 2012). Hence it becomes important to integrate DNA methylation data with gene 314	  
expression profiles. In the recent study combined analysis of gene expression in addition to the DNA methylation 315	  
was carried out for a select number of genes. DAVID analysis identifies neuronal development, synaptic 316	  
transmission and apoptosis as common pathways involved in Mn induced Parkinsonism. 317	  
Clinically, Parkinson’s disease is accompanied by motor dysfunction because of dopamine depletion occurring as a 318	  
result of dopaminergic neuronal degeneration within the substantianigra pars compacta (SNpc) (Ammal Kaidery et 319	  
al. 2013).Five genetic loci, including α-synuclein, parkin, PINK1, DJ-1, and LRRK2 are the most extensively 320	  
studied and considered as critical risk factors for the onset of sporadic Parkinson’s disease (Rochet  and Hay 2012). 321	  
In the present study activity of two genetic loci, parkin and PINK1 was found to be altered via hypermethylation 322	  
upon manganese exposure. 323	  
Tyrosine hydroxylase (TH) has an important role in dopamine biosynthesis. Mn exposure has been found to alter the 324	  
activity of TH, both in dopaminergic neuronal cells and a Zebrafish model of manganism (Zhang et al. 2011; 325	  
Bakthavatsalam et al. 2014). The result of the present investigation suggests that cytosine methylation plays a role in 326	  
modulating TH gene activity and may contribute to diminished expression levels, which is in agreement with 327	  
previous studies on Mn neurotoxicity (Bakthavatsalam et al. 2014).. However, our results require further validation 328	  
and testingin other animal models. 329	  
Parkin/PARK2 is an autosomal recessive gene and mutations in one of the alleles has been shown to cause the 330	  
clinical features of Parkinsonism and as risk factor for early onset of Parkinson’s disease (EOPD) (Periquet M et al. 331	  
2003; Padmaja et al.2012)The present study suggests that hypermethylation of PARK2 with subsequent reduction in 332	  
gene expression may be another molecular mechanism that potentiates Mn toxicity via loss of control over Divalent 333	  
Metal Transporter (DMT1) mediated Mn transport(Roth and Garrick 2003; Higashi et al. 2004).  334	  
PINK1 is a serine/threonine kinase with neuroprotective function that localizes to mitochondria (Petit et al. 2005; 335	  
Silvestri et al. 2005). We found PINK1 expression to be decreased in the present study, presumably through 336	  
hypermethylation of the gene. Perturbation in PINK1 function through mutation has been reported to cause 337	  
impairment of mitochondrial function, synaptic transmission and elevated sensitivity to oxidative stress (Kitada et 338	  
al. 2008). PINK1 has also been found to interact with polycomb histone-methylation modulator (EED/WAIT1) and 339	  
regulate gene expression during SH-SY5Y differentiation (Berthier et al. 2013).  340	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PARK2 and PINK1 have been identified as key genes responsible for early onset of Parkinsonism via loss of 341	  
mitochondrial quality control (Noriyuki Matsuda 2015). Mitochondrial quality control is an essential function of 342	  
healthy neurons ensuring cell survival, while dysfunction of complex I has been reported to induce Parkinsonism 343	  
and sporadic Parkinson’s disease (Schapira 2008). Parkin/PARK2 is selectively targeted to depolarized 344	  
mitochondria to facilitate the removal of damaged mitochondria through ubiquitination of outer mitochondrial 345	  
substrate (Narendra et al. 2010). PINK1 kinase activity is responsible for both activation and recruitment of PARK2 346	  
to mitochondrial membrane (Youle 2014). Initially, PINK1 phosphorylate ubiquitin on depolarized mitochondria 347	  
that function as an activator of PARK2 activity through repression of auto-inhibiting activity of PARK2  (Trempe et 348	  
al. 2013). The subsequent events of ubiquitin-phosphorylation act as a signal for PINK1-PARK2 mediated 349	  
mitophagy based removal of depolarized mitochondria (De-Chen et al. 2015). The findings suggest that PINK1-350	  
PARK2 together have a vital role in regulating mitochondrial quality control and thereby appear to prevent the onset 351	  
of Parkinsonism (Narendra, et at. 2012; Youle 2014). DNA methylation studies in manganese exposed mouse model 352	  
recently reported alteration to several mitochondrial genes (Yang et al. 2016).Epigenetic down-regulation of both 353	  
PINK1-PARK2 through hypermetylation in the present study supports the previous findings and supports the 354	  
concept that mitochondrial dysfunction might be responsible for Mn induced Parkinsonism. 355	  
This is one of the first studies to reveal manganese induced alterations in DNA methylation. The results indicate the 356	  
influence of chronic manganese exposure on epigenetic de-regulation of Parkinson’s disease associated pathways. 357	  
Our data, along with those communicated by Yang and colleagues (Yang et al. 2016) signify the importance of 358	  
considering the role of epigenetic mechanisms in Mn induced neurotoxic effects. These results  require  validation 359	  
and replication in other animal models of Parkinson’s disease. 360	  
 361	  
5. Conclusion 362	  
The study shows that chronic manganese exposure on dopaminergic human neuroblastoma cells (SH-SY5Y) induces 363	  
global alteration to DNA methylation levels of genes involved in biological pathways, including neuronal 364	  
development and differentiation, synaptic transmission, signal transduction, and inflammation. Mitochondrial 365	  
dysfunction is known to be involved in Parkinsonism and Mn has also been shown to alter mitochondrial function. 366	  
The present study suggests an epigenetic alteration of PINK1-PARK2 which might contribute to the Mn mediated 367	  
mitochondrial dysfunction and probably in the etiology of Parkinson’s disease. A better understanding of Mn 368	  
induced neurotoxicity and an altered epigenetic landscape that comes along with Mn exposure could lead to the 369	  
identification of new prognostic and therapeutic epigenetic targets. 370	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 374	  
Figure legends 375	  
Figure 1. Overall methylation densities (%) from the single-base resolution methylomes (WGBSdata) were 376	  
determined for(A)cytosines atCpGsitesand (B)cytosines atnon-CpG sites.Non-CpG methylationof cytosines is 377	  
categorized in the context of CHG and CHH sequences, where H = A/C/T. The frequencies of these cytosine 378	  
methylation events for different CHG and CHH sequence combinations is shown for the control(C) and the 379	  
manganese-treated sample (D). The WGBS-approachgenerates sequence data for both, the reference sequenceof the 380	  
genome (‘Watson’ DNA strand) and the sequence of the complementary DNA strand (‘Crick’DNA strand). 381	  
Methylation densities do not show any obvious strand bias. 382	  
Figure 2. DAVID database was used for the Gene Ontology (GO) functional annotation cluster analysis. The figure 383	  
depicts the major biological pathways associated with (A) Hypermethylated and (B) Hypomethylated genes.  384	  
Figure 3. Gene Ontology (GO) functional annotation cluster analysis was performed using DAVID database for 385	  
differentially expressed genes identified in PCR array for Human Parkinson’s Disease.  386	  
Figure 4.Heatmap clustering of 119 genes screened based on involvement in Parkinson’s disease pathways. Red and 387	  
green colors represent the high and low level of DNA methylation.  388	  
Figure 5.Relative gene expression level of the selected genes in Human Parkinson's Disease RT² Profiler PCR 389	  
Array.Error bar represent the standard error (SE) and * indicates statistical significance (p<0.05).  390	  
Figure 6. The STRING database (Search Tool for the Retrieval of Interacting Genes/Proteins) based analysis shows 391	  
the functional association between the genes.  Protein-protein interaction (PPI) enrichment p-value, highlighted in 392	  
blue box indicates significant interaction and biological association between genes as a group. Biological process 393	  
(GO) and genes in network highlighted in red box represent the process deregulated in Parkinson’s disease pathway.  394	  
Table 1. Table depicting the genes identified on correlation between genes in DNA methylation and RT2 profiler 395	  
array for Parkinson’s disease. Table shows the biological function of the genes listed  396	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